Sign In
Buy CRSP
$48.15
+1.16 (+2.47%)
At Close: Jul 21, 2026
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
09:17am, Saturday, 25'th Mar 2023
CRISPR could revolutionize the way we treat thousands of diseases. Currently, there are about 7,000 caused by genetic disorders, which occur when a mutation affects your genes, or when you have the wr
The Cream Of The Crop: 5 Biotech Stocks That Outrank 91% Of All Stocks
12:33pm, Friday, 24'th Mar 2023
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
This Cathie Wood Stock Could Nearly Double, According to Wall Street
10:07am, Thursday, 23'rd Mar 2023
CRISPR Therapeutics is closing in on an important regulatory event. The FDA is considering its potential gene-editing therapy for sickle cell disease.
Here's Why You Should Add CRISPR Stock to Your Portfolio
01:46pm, Tuesday, 21'st Mar 2023
CRISPR Therapeutics (CRSP), a top-ranked stock at present, is developing its lead pipeline candidate to treat TDT and SCD.
4 Biotech Stocks to Consider for Your Portfolio in 2023
01:00pm, Tuesday, 21'st Mar 2023
New drug approvals and pipeline progress should maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and a solid pipeline progress position CRSP, LGND, THRX and KAL
3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time
07:18pm, Saturday, 18'th Mar 2023
Healthcare costs in America and the world are set to rise in the foreseeable future. All thanks to an aging population, and the expectation that healthcare companies will be able to cure more of our d
CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting
06:02pm, Tuesday, 14'th Mar 2023
ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious dis
Missed Out on Vertex? My Best Gene-Editing Stock to Buy and Hold
08:50am, Thursday, 09'th Mar 2023
CRISPR Therapeutics is a clinical-stage biotech company. The company's pipeline includes two promising wholly owned therapies.
2 Healthcare Stocks That Could Help Make You a Fortune
02:00pm, Wednesday, 08'th Mar 2023
CRISPR Therapeutics' first potential product may bring in blockbuster revenue. Intuitive Surgical is a leader by far -- in a market growing in the double-digits.
7 Cathie Wood Stocks for Your March Buy List
02:48pm, Tuesday, 07'th Mar 2023
Investing in Cathie Wood stocks means directing your money toward innovation. And that means investing heavily in tech, a sector that has been pummeled by interest rates held higher by a Federal Reser
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing
12:13pm, Monday, 06'th Mar 2023
The 2022 Nobel Prize in Chemistry went to Emmanuelle Charpentier and Jennifer Doudna for their work on developing tools to change the genetic code of living cells, tools called CRISPR/Cas. Yet long be
Better Growth Stock: Moderna vs. CRISPR Therapeutics
05:30am, Sunday, 05'th Mar 2023
Moderna's pipeline programs may drive another huge phase of growth. The potential approval of CRISPR's first product could be a major catalyst for the stock.
3 Things About CRISPR Therapeutics That Smart Investors Know
07:25am, Saturday, 04'th Mar 2023
Institutional investors might be on to something.
2 Soaring Stocks to Buy and Hold Through 2023 and Beyond
09:15am, Friday, 03'rd Mar 2023
Investors are bidding up shares of these companies, and there are good reasons for doing so.
Intellia Therapeutics Stock Surges On A First-Ever In CRISPR Gene Editing
09:24am, Thursday, 02'nd Mar 2023
The FDA cleared Intellia to begin testing its CRISPR gene-editing technology in people on Thursday, leading NTLA stock to jump. The post Intellia Therapeutics Stock Surges On A First-Ever In CRISPR Ge
